Patryk Mikucki
Technik-/Wissenschafts-/F&E-Leiter bei ALEXION PHARMACEUTICALS, INC.
Ursprung des Netzwerks ersten Grades von Patryk Mikucki
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 14 | |
| Public Company | Medical Specialties | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Patryk Mikucki
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Curiosity Diagnostics Sp Zoo
 Curiosity Diagnostics Sp Zoo Miscellaneous Commercial ServicesCommercial Services Part of Bio-Rad Laboratories, Inc., Curiosity Diagnostics Sp zoo is a Polish company that develops technology solutions for medical diagnostic and healthcare markets. The company is based in Warsaw, Poland. The company was founded by Szymon Ruta, Marcin Izydorzak, Piotr Garstecki. Marcin Izydorzak has been the CEO since incorporation. Curiosity Diagnostics was acquired by Bio-Rad Laboratories, Inc. from Scope Fluidics SA on August 03, 2022 for $36.98 million. | Miscellaneous Commercial Services | Founder Founder Chief Executive Officer | |
| University of Warsaw | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CATALYST PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Trident University International | College/University | Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Alexion Charitable Foundation | Chairman | ||
| AVIDITY BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Hamilton College (New York) | College/University | Undergraduate Degree | |
| Università Campus Bio-Medico di Roma | College/University | Doctorate Degree | |
| Sapienza University of Rome | College/University | Doctorate Degree | |
| TREX WIND-DOWN, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Instytut Chemii Fizycznej Pan | Corporate Officer/Principal | ||
| Polish Academy of Sciences | College/University | Doctorate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| BLUEBIRD BIO, INC. | Biotechnology | Corporate Officer/Principal | |
TTL 1 Sp zoo
 TTL 1 Sp zoo Financial ConglomeratesFinance Part of IPOPEMA Securities SA, TTL 1 Sp zoo provides investment services. The company is based in Warsaw, Poland. | Financial Conglomerates | Corporate Officer/Principal | |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Brown University | College/University | Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Compliance Officer | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Compliance Officer | |
| State University of New York at Downstate Medical Center | College/University | Doctorate Degree | |
| State University of New York College at Oneonta | College/University | Undergraduate Degree | |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Oxeia Biopharmaceuticals, Inc.
 Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| University of Warwick | College/University | Masters Business Admin | |
| International Project Management Association Polska | Corporate Officer/Principal | ||
| University of Szczecin | College/University | Corporate Officer/Principal | |
| Warsaw School of Economics | College/University | Graduate Degree | |
| RANDSTAD N.V. | Personnel Services | Director/Board Member | |
ConsenSys Software, Inc.
 ConsenSys Software, Inc. Packaged SoftwareTechnology Services ConsenSys Software, Inc. provides market block chain technology services. Its products are Infura, Quorum, Codefi, MetaMask, and Diligence. It offer solutions to the asset management, capital markets, decentralized finance, global trade and commerce, payments and money, and all solutions and use cases. The company was founded by Joseph Lubin in 2014 and is headquartered in Brooklyn, NY. | Packaged Software | Human Resources Officer | |
| SKANSKA AB | Homebuilding | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Sales & Marketing | |
| 2SEVENTY BIO, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Total Fundusz Inwestycyjny Zamkniety
 Total Fundusz Inwestycyjny Zamkniety Investment Trusts/Mutual FundsMiscellaneous Total Fundusz Inwestycyjny Zamkniety operates as a closed-end investment fund. It invests in shares and derivatives listed on the WSE, in ETFs for various asset classes, and on foreign markets. The company was founded by Konrad Marek Lapinski in 2008 and is headquartered in Warsaw, Poland. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Skarbiec TFI SA
 Skarbiec TFI SA Investment ManagersFinance Skarbiec TFI SA is the wholly-owned investment management subsidiary of Skarbiec Holding SA (WSE: SKH) in Poland. The firm was founded in 1997 and formerly known as Skarbiec Investment Management. Headquartered in Warsaw, Skarbiec manages mutual funds and offers specialized investment services addressed to wealthy private clients as well as institutional entities - companies, financial institutions, foundations or associations that have financial surpluses. | Investment Managers | Corporate Officer/Principal | |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Pervasis Therapeutics, Inc.
 Pervasis Therapeutics, Inc. Medical SpecialtiesHealth Technology Pervasis Therapeutics, Inc. is a clinical stage company developing a broad portfolio of biologically active therapeutics. The company was founded by Robert S. Langer Jr. and Helen Marie Nugent in 2004 and is headquartered in Waltham, MA. | Medical Specialties | Chief Executive Officer | |
MYOSIX SA
 MYOSIX SA BiotechnologyHealth Technology MYOSIX SA develops cell-based therapeutics. The company is involved in the development of autologous cell therapy products for the treatment of cardiopathies and certain forms of myopathy in humans. MYOSIX specializes in the development of cell-based therapeutics against other pathologies like cancers. MYOSIX is also engaged in a number of R&D projects and develops a cell and tissue bank for therapeutic or R&D purposes. The company was founded by Vilquin, Marolleau, Scorsin, Eisenmann and Halioua in 2000 and is headquartered in Saint-Germain-en-Laye, France. | Biotechnology | Chief Executive Officer | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member | |
| Alexion Pharmaceuticals, Inc. /New/ | Chief Executive Officer | ||
AstraZeneca KK
 AstraZeneca KK Pharmaceuticals: MajorHealth Technology AstraZeneca KK develops, manufactures and sells prescription drugs. It also conducts medical research. The company was founded on April 11, 1975 and is headquartered in Osaka, Japan. | Pharmaceuticals: Major | Chairman | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Astrazeneca Intermediate Holdings Ltd.
 Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Intermediate Holdings Ltd. operates as a British intermediate holding company through its subsidiaries and researches, manufactures, and markets pharmaceuticals. The company is based in Cambridge, UK. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 26 |
| Polen | 12 |
| Vereinigtes Königreich | 6 |
| Frankreich | 5 |
| Italien | 3 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Finance | 3 |
| Technology Services | 2 |
Operativ
| Corporate Officer/Principal | 30 |
| Director/Board Member | 27 |
| Chief Executive Officer | 7 |
| Chairman | 7 |
| Founder | 6 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Patryk Mikucki
- Unternehmensverbindungen
